BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 33099354)

  • 21. Optimal extent of resection for glioblastoma according to site, extension, and size: a population-based study in the temozolomide era.
    Kim YJ; Lee DJ; Park CK; Kim IA
    Neurosurg Rev; 2019 Dec; 42(4):937-950. PubMed ID: 30612289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA methylation subclasses predict the benefit from gross total tumor resection in IDH-wildtype glioblastoma patients.
    Drexler R; Schüller U; Eckhardt A; Filipski K; Hartung TI; Harter PN; Divé I; Forster MT; Czabanka M; Jelgersma C; Onken J; Vajkoczy P; Capper D; Siewert C; Sauvigny T; Lamszus K; Westphal M; Dührsen L; Ricklefs FL
    Neuro Oncol; 2023 Feb; 25(2):315-325. PubMed ID: 35868257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is There an Indication for Intraoperative MRI in Subtotal Resection of Glioblastoma? A Multicenter Retrospective Comparative Analysis.
    Coburger J; Segovia von Riehm J; Ganslandt O; Wirtz CR; Renovanz M
    World Neurosurg; 2018 Feb; 110():e389-e397. PubMed ID: 29138078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Survival benefit of lobectomy for glioblastoma: moving towards radical supramaximal resection.
    Shah AH; Mahavadi A; Di L; Sanjurjo A; Eichberg DG; Borowy V; Figueroa J; Luther E; de la Fuente MI; Semonche A; Ivan ME; Komotar RJ
    J Neurooncol; 2020 Jul; 148(3):501-508. PubMed ID: 32627128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term survival after glioblastoma resection: hope despite poor prognosis factors.
    Costa E; Lawson TM; Lelotte J; Fomekong E; Vaz RG; Renard L; Whenham N; Raftopoulos C
    J Neurosurg Sci; 2019 Jun; 63(3):251-257. PubMed ID: 29363298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Superior Efficacy of Gross Total Resection in Anaplastic Astrocytoma Patients Relative to Glioblastoma Patients.
    Padwal JA; Dong X; Hirshman BR; Hoi-Sang U; Carter BS; Chen CC
    World Neurosurg; 2016 Jun; 90():186-193. PubMed ID: 26924115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Threshold of the extent of resection for WHO Grade III gliomas: retrospective volumetric analysis of 122 cases using intraoperative MRI.
    Fujii Y; Muragaki Y; Maruyama T; Nitta M; Saito T; Ikuta S; Iseki H; Hongo K; Kawamata T
    J Neurosurg; 2018 Jul; 129(1):1-9. PubMed ID: 28885120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Volumetric Analysis Using Low-Field Intraoperative Magnetic Resonance Imaging for 168 Newly Diagnosed Supratentorial Glioblastomas: Effects of Extent of Resection and Residual Tumor Volume on Survival and Recurrence.
    Fukui A; Muragaki Y; Saito T; Maruyama T; Nitta M; Ikuta S; Kawamata T
    World Neurosurg; 2017 Feb; 98():73-80. PubMed ID: 27989974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dual-Use Intraoperative MRI in Glioblastoma Surgery: Results of Resection, Histopathologic Assessment, and Surgical Site Infections.
    Wach J; Goetz C; Shareghi K; Scholz T; Heßelmann V; Mager AK; Gottschalk J; Vatter H; Kremer P
    J Neurol Surg A Cent Eur Neurosurg; 2019 Nov; 80(6):413-422. PubMed ID: 31272122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determining a cut-off residual tumor volume threshold for patients with newly diagnosed glioblastoma treated with temozolomide chemoradiotherapy: A multicenter cohort study.
    Woo PYM; Ho JMK; Tse TPK; Lam SW; Mak CHK; Chan DTM; Lee MWY; Wong ST; Chan KY; Poon WS
    J Clin Neurosci; 2019 May; 63():134-141. PubMed ID: 30712777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Counseling Patients with a Glioblastoma Amenable Only for Subtotal Resection: Results of a Multicenter Retrospective Assessment of Survival and Neurologic Outcome.
    Coburger J; Segovia J; Ganslandt O; Ringel F; Wirtz CR; Renovanz M
    World Neurosurg; 2018 Jun; 114():e1180-e1185. PubMed ID: 29621607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of supramarginal resection on survival outcomes after gross-total resection of IDH-wild-type glioblastoma.
    Vivas-Buitrago T; Domingo RA; Tripathi S; De Biase G; Brown D; Akinduro OO; Ramos-Fresnedo A; Sabsevitz DS; Bendok BR; Sherman W; Parney IF; Jentoft ME; Middlebrooks EH; Meyer FB; Chaichana KL; Quinones-Hinojosa A
    J Neurosurg; 2022 Jan; 136(1):1-8. PubMed ID: 34087795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surgery for Diffuse WHO Grade II Gliomas: Volumetric Analysis of a Multicenter Retrospective Cohort From the German Study Group for Intraoperative Magnetic Resonance Imaging.
    Scherer M; Ahmeti H; Roder C; Gessler F; Jungk C; Pala A; Mayer B; Senft C; Tatagiba M; Synowitz M; Wirtz CR; Unterberg AW; Coburger J
    Neurosurgery; 2020 Jan; 86(1):E64-E74. PubMed ID: 31574147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T2 Fluid-Attenuated Inversion Recovery Resection for Glioblastoma Involving Eloquent Brain Areas Facilitated Through Awake Craniotomy and Clinical Outcome.
    Lu M; Fu ZH; He XJ; Lu JK; Deng XQ; Lin DL; Gu YM; Fan YF; Lai MY; Li J; Yang MM; Chen ZP
    World Neurosurg; 2020 Mar; 135():e738-e747. PubMed ID: 31899397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of new or worsened postoperative neurological deficits on survival of patients with glioblastoma.
    Rahman M; Abbatematteo J; De Leo EK; Kubilis PS; Vaziri S; Bova F; Sayour E; Mitchell D; Quinones-Hinojosa A
    J Neurosurg; 2017 Jul; 127(1):123-131. PubMed ID: 27689459
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An extent of resection threshold for recurrent glioblastoma and its risk for neurological morbidity.
    Oppenlander ME; Wolf AB; Snyder LA; Bina R; Wilson JR; Coons SW; Ashby LS; Brachman D; Nakaji P; Porter RW; Smith KA; Spetzler RF; Sanai N
    J Neurosurg; 2014 Apr; 120(4):846-53. PubMed ID: 24484232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An extent of resection threshold for newly diagnosed glioblastomas.
    Sanai N; Polley MY; McDermott MW; Parsa AT; Berger MS
    J Neurosurg; 2011 Jul; 115(1):3-8. PubMed ID: 21417701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patient-Specific Resection Strategy of Glioblastoma Multiforme: Choice Based on a Preoperative Scoring Scale.
    Jiang H; Cui Y; Liu X; Ren X; Lin S
    Ann Surg Oncol; 2017 Jul; 24(7):2006-2014. PubMed ID: 28321691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survival Benefit of Maximal Resection for Glioblastoma Reoperation in the Temozolomide Era: A Meta-Analysis.
    Lu VM; Goyal A; Graffeo CS; Perry A; Burns TC; Parney IF; Quinones-Hinojosa A; Chaichana KL
    World Neurosurg; 2019 Jul; 127():31-37. PubMed ID: 30947000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postoperative outcomes following glioblastoma resection using a robot-assisted digital surgical exoscope: a case series.
    Baron RB; Lakomkin N; Schupper AJ; Nistal D; Nael K; Price G; Hadjipanayis CG
    J Neurooncol; 2020 Jul; 148(3):519-527. PubMed ID: 32519286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.